Pages that link to "Q38364124"
Jump to navigation
Jump to search
The following pages link to Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation (Q38364124):
Displaying 14 items.
- NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice (Q33627534) (← links)
- Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy (Q33740554) (← links)
- FTO is a relevant factor for the development of the metabolic syndrome in mice (Q34075518) (← links)
- Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome (Q34644169) (← links)
- NPY receptors as potential targets for anti-obesity drug development (Q35130522) (← links)
- Updating experimental models of diabetic cardiomyopathy (Q35564129) (← links)
- Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models (Q35586608) (← links)
- Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants (Q37697371) (← links)
- The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer (Q37857947) (← links)
- Current views on neuropeptide Y and diabetes-related atherosclerosis (Q39250869) (← links)
- Differentially functionalized diamines as novel ligands for the NPY2 receptor (Q40617684) (← links)
- Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus (Q44750698) (← links)
- Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice (Q48492969) (← links)
- Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice. (Q55338938) (← links)